Project Grant R01MH137804

Award Date 9/11/24
Completion Date 6/30/29
Dollars Obligated $710K
Federal Grant Program
93.242
Assistance Type
Project Grant
Place of Performance
Research Triangle Park, Durham, NC, USA
Similar Awards
This Project Grant award of $665,225 from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants (CFDA 93.242) program, will fund the "SUUBI4PREP: Improving PrEP Access and Adherence among Adolescent Girls and Young Women in Uganda" project. The project aims to implement a multilevel combination intervention focused on increasing pre-exposure prophylaxis (PrEP) initiation and adherence among adolescent girls and young women living in HIV hotspots in...
This $715,041 Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) will support research to understand real-world choices, preferences, and outcomes related to the roll-out of oral and long-acting injectable PrEP (pre-exposure prophylaxis) among women in Malawi. The study, titled "Better Info on Women's PrEP Choices and Outcomes in Malawi", has three specific aims: 1) Evaluate longitudinal patterns of oral...
This $262,627 Project Grant award from the National Institute of Mental Health (CFDA 93.242 Mental Health Research Grants) supports the development and testing of a novel peer navigator mHealth intervention to increase uptake of pre-exposure prophylaxis (PrEP) and modern contraception among female university students in Zambia. The key products and services to be delivered under this grant include: Adapting an existing app, PEBRA, using human-centered design and qualitative methods to create a...
The National Institute of Mental Health (NIMH) awarded a $780,447 Project Grant (CFDA 93.242 - Mental Health Research Grants) to Brigham & Women's Hospital Inc. to test a differentiated service delivery model called CARES-DSD to improve engagement and viral suppression among people with HIV who have experienced treatment interruptions in South Africa. The 5-year project will recruit 300 participants from an ongoing study and evaluate the effectiveness of the CARES-DSD intervention compared...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) provides $381,487 to the University of Maryland, Baltimore (UMB) to assess the early implementation of long-acting injectable cabotegravir (CAB-LA) pre-exposure prophylaxis (PrEP) among adolescent girls and young women (AGYW) at high risk of HIV acquisition in Zambia. The key objectives are to: 1) Evaluate implementation determinants of CAB-LA...
This Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) supports a $1,554,880 initiative titled "Integrating PrEP Decision-Making into Contraceptive Counseling in Family Planning Clinics". The award aims to expand and enhance an existing PrEP decision aid, and integrate its delivery into sexual and reproductive health settings during contraceptive counseling visits, to increase PrEP access and uptake...
This Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) will fund a cluster randomized controlled trial to test the impact of a long-term, dynamic choice intervention on 12-month viral suppression among HIV clients experiencing treatment interruption in Malawi. The $653,677 award will be used to implement this research initiative over a project period from April 1, 2025 to January 31, 2030. The goal is to...
This federal Project Grant award of $1,365,212 from the National Institute of Mental Health (CFDA 93.242 - Mental Health Research Grants) aims to optimize and test a peer-led dynamic choice HIV prevention intervention to increase coverage of biomedical prevention products among women at elevated HIV risk in southwestern Uganda. The project will refine the existing Search Dynamic Choice HIV Prevention (DCP) intervention to further engage women working in venues where transactional sex is...
This $233,335 National Institute of Mental Health project grant supports the adaptation and optimization of the Friendship Bench mental health intervention for adolescent girls and young women in South African HIV pre-exposure prophylaxis (PrEP) delivery settings. The University of Washington will receive funding to support Dr. Jennifer Velloza's development as an independent researcher focused on improving mental health intervention delivery integrated with HIV prevention services for young...
This Project Grant award of $197,035 from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) will fund a 5-year study to design and evaluate a community-based intervention to engage men who use alcohol and substances in HIV prevention services in rural South Africa. The primary objectives are to: 1) explore perceptions and preferences for HIV prevention services among men who frequent local bars (shebeens), 2) develop an intervention...

This Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), aims to adapt and evaluate the effectiveness of the Comprehensive Adherence Resource and Empowerment Support (CARES) intervention to increase pre-exposure prophylaxis (PrEP) continuation and adherence among adolescent girls and young women in South Africa and Zimbabwe.

The total funding amount is $710,187, with an award date of September 11, 2024 and an ultimate completion date of June 30, 2029. The award is led by multiple principal investigators from RTI International, Desmond Tutu HIV Foundation, and Pangaea Zimbabwe AIDS Trust. Sub-awards have been made to the University of Illinois, Desmond Tutu Health Foundation, and FHI 360 to support various aspects of the research and implementation. The overarching goals are to adapt the CARES intervention to be implementable in real-world settings, incorporate injectable PrEP, and evaluate the effectiveness, feasibility, acceptability, and fidelity of the adapted intervention.

Generated 7/1/25, 2:14 AM